 | • レポートコード：MRC2308A074 • 出版社/出版日：Transparency Market Research / 2023年6月20日 • レポート形態：英文、PDF、244ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ベンゾジアゼピンAPI市場 - レポートの範囲TMRの調査レポート「ベンゾジアゼピンAPIの世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界のベンゾジアゼピンAPI市場の収益を提供します。また、2023年から2031年までのベンゾジアゼピンAPIの世界市場の複合年間成長率（CAGR %）も掲載しています。 本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、ベンゾジアゼピンAPI市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照しました。 二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストは、世界のベンゾジアゼピンAPI市場の様々な属性を調査するために、トップダウンアプローチとボトムアップアプローチの組み合わせを採用しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界のベンゾジアゼピンAPI市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場プレイヤーだけでなく、世界のベンゾジアゼピンAPI市場への参入に関心のある企業にとっても貴重なツールとなります。 当レポートでは、世界のベンゾジアゼピンAPI市場の競争環境について調査しています。世界のベンゾジアゼピンAPI市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートでプロファイリングされた世界のベンゾジアゼピンAPI市場におけるプレイヤーの項目です。 世界のベンゾジアゼピンAPI市場レポートで回答された主な内容 - 予測期間中の全地域におけるベンゾジアゼピンAPIの売上高/収益 - 世界のベンゾジアゼピンAPI市場におけるビジネスチャンス - 市場の主な促進要因、阻害要因、機会、脅威 - 予測期間中に最も速いCAGRで拡大する地域市場 - 2031年に世界で最も高い収益を上げると予測されるセグメント - 予測期間中に最も高いCAGRで拡大すると予測されるセグメント - 世界市場で事業を展開する各企業の市場ポジション ベンゾジアゼピンAPI市場 - 調査目的と調査アプローチ この調査レポートは、ベンゾジアゼピンAPIの世界市場に関する包括的な報告書です。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーや流通業者、製品承認のための規制シナリオについて詳しく解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフと表を適切に配置した網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化することで、読者に視覚的に訴えかけます。また、過去と予測期間末の主要セグメントの市場シェアの比較も可能です。 当レポートでは、世界のベンゾジアゼピンAPI市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界のベンゾジアゼピンAPIへの投資について、情報に基づいたビジネス上の意思決定を行うことができます。 |
1. 序論
2. 仮定・調査手法
3. エグゼクティブサマリー
4. 市場概要
5. キーインサイト
6. ベンゾジアゼピンAPIの世界市場分析＆予測：製品別
7. ベンゾジアゼピンAPIの世界市場分析＆予測：作用時間別
8. ベンゾジアゼピンAPIの世界市場分析＆予測：エンドユーザー別
9. ベンゾジアゼピンAPIの世界市場分析＆予測：地域別
10. 北米のベンゾジアゼピンAPI市場分析＆予測
11. ヨーロッパのベンゾジアゼピンAPI市場分析＆予測
12. アジア太平洋地域のベンゾジアゼピンAPI市場分析＆予測
13. 中南米のベンゾジアゼピンAPI市場分析＆予測
14. 中東・アフリカのベンゾジアゼピンAPI市場分析＆予測
15. 競争状況
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Benzodiazepine APIs Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Benzodiazepine APIs Market Analysis and Forecast, 2017 – 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Benzodiazepine Application Overview
5.2. Regulatory Scenario for Benzodiazepines in China and U.S.
5.3. Top 3 Markets for Clonazepam in Europe
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term impact)
6. Global Benzodiazepine APIs Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017 – 2031
6.3.1. Alprazolam
6.3.2. Bromazepam
6.3.3. Chlordiazepoxide
6.3.4. Clobazam
6.3.5. Clonazepam
6.3.6. Clorazepate
6.3.7. Diazepam
6.3.8. Lorazepam
6.3.9. Midazolam
6.3.10. Nitrazepam
6.3.11. Oxazepam
6.3.12. Temazepam
6.3.13. Others
6.4. Market Attractiveness, by Product
7. Global Benzodiazepine APIs Market Analysis and Forecast, by Time of Action
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Time of Action, 2017 – 2031
7.3.1. Short Acting
7.3.2. Intermediate
7.3.3. Long Acting
7.4. Market Attractiveness, by Time of Action
8. Global Benzodiazepine APIs Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017 – 2031
8.3.1. Pharmaceutical & Biotechnology Industries
8.3.2. CMOs
8.3.3. Others (Research Institutes, etc.)
8.4. Market Attractiveness, by End-user
9. Global Benzodiazepine APIs Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Benzodiazepine APIs Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017 – 2031
10.2.1. Alprazolam
10.2.2. Bromazepam
10.2.3. Chlordiazepoxide
10.2.4. Clobazam
10.2.5. Clonazepam
10.2.6. Clorazepate
10.2.7. Diazepam
10.2.8. Lorazepam
10.2.9. Midazolam
10.2.10. Nitrazepam
10.2.11. Oxazepam
10.2.12. Temazepam
10.2.13. Others
10.3. Market Value Forecast, by Time of Action, 2017 – 2031
10.3.1. Short Acting
10.3.2. Intermediate
10.3.3. Long Acting
10.4. Market Value Forecast, by End-user, 2017 – 2031
10.4.1. Pharmaceutical & Biotechnology Industries
10.4.2. CMOs
10.4.3. Others (Research Institutes, etc.)
10.5. Market Value Forecast, by Country, 2017 – 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Time of Action
10.6.3. By End-user
10.6.4. By Country
11. Europe Benzodiazepine APIs Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017 – 2031
11.2.1. Alprazolam
11.2.2. Bromazepam
11.2.3. Chlordiazepoxide
11.2.4. Clobazam
11.2.5. Clonazepam
11.2.6. Clorazepate
11.2.7. Diazepam
11.2.8. Lorazepam
11.2.9. Midazolam
11.2.10. Nitrazepam
11.2.11. Oxazepam
11.2.12. Temazepam
11.2.13. Others
11.3. Market Value Forecast, by Time of Action, 2017 – 2031
11.3.1. Short Acting
11.3.2. Intermediate
11.3.3. Long Acting
11.4. Market Value Forecast, by End-user, 2017 – 2031
11.4.1. Pharmaceutical & Biotechnology Industries
11.4.2. CMOs
11.4.3. Others (Research Institutes, etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Time of Action
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Benzodiazepine APIs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017 – 2031
12.2.1. Alprazolam
12.2.2. Bromazepam
12.2.3. Chlordiazepoxide
12.2.4. Clobazam
12.2.5. Clonazepam
12.2.6. Clorazepate
12.2.7. Diazepam
12.2.8. Lorazepam
12.2.9. Midazolam
12.2.10. Nitrazepam
12.2.11. Oxazepam
12.2.12. Temazepam
12.2.13. Others
12.3. Market Value Forecast, by Time of Action, 2017 – 2031
12.3.1. Short Acting
12.3.2. Intermediate
12.3.3. Long Acting
12.4. Market Value Forecast, by End-user, 2017 – 2031
12.4.1. Pharmaceutical & Biotechnology Industries
12.4.2. CMOs
12.4.3. Others (Research Institutes, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Time of Action
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Benzodiazepine APIs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017 – 2031
13.2.1. Alprazolam
13.2.2. Bromazepam
13.2.3. Chlordiazepoxide
13.2.4. Clobazam
13.2.5. Clonazepam
13.2.6. Clorazepate
13.2.7. Diazepam
13.2.8. Lorazepam
13.2.9. Midazolam
13.2.10. Nitrazepam
13.2.11. Oxazepam
13.2.12. Temazepam
13.2.13. Others
13.3. Market Value Forecast, by Time of Action, 2017 – 2031
13.3.1. Short Acting
13.3.2. Intermediate
13.3.3. Long Acting
13.4. Market Value Forecast, by End-user, 2017 – 2031
13.4.1. Pharmaceutical & Biotechnology Industries
13.4.2. CMOs
13.4.3. Others (Research Institutes, etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Time of Action
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Benzodiazepine APIs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017 – 2031
14.2.1. Alprazolam
14.2.2. Bromazepam
14.2.3. Chlordiazepoxide
14.2.4. Clobazam
14.2.5. Clonazepam
14.2.6. Clorazepate
14.2.7. Diazepam
14.2.8. Lorazepam
14.2.9. Midazolam
14.2.10. Nitrazepam
14.2.11. Oxazepam
14.2.12. Temazepam
14.2.13. Others
14.3. Market Value Forecast, by Time of Action, 2017 – 2031
14.3.1. Short Acting
14.3.2. Intermediate
14.3.3. Long Acting
14.4. Market Value Forecast, by End-user, 2017 – 2031
14.4.1. Pharmaceutical & Biotechnology Industries
14.4.2. CMOs
14.4.3. Others (Research Institutes, etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Time of Action
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Sun Pharmaceutical Industries Ltd.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Merck KGaA
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. LGC GmbH (LGC Science Group Holdings Limited)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Nortec Química S.A.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Centaur Pharmaceuticals
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Eisai Co., Ltd
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Global Calcium PVT LTD
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Delphis Pharma
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Mylan N.V. (Viatris Inc.)
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Taj Pharmaceuticals Ltd.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
Table 01: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 02: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 03: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 04: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 06: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 07: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 08: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 09: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 10: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 11: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 12: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 13: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 14: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 15: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 16: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 17: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 18: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 19: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 20: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 21: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 22: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 23: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 24: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 25: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 26: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 27: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 28: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 29: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 30: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 31: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 32: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 33: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 34: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 35: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 36: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 37: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 38: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 39: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 40: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017-2031
Table 41: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 42: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 43: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 44: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 45: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 46: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 47: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 48: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 49: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 50: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 51: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 52: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 53: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 54: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 55: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 56: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 57: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 58: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 59: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 60: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 61: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 62: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 63: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 64: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 65: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 66: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 67: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 68: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 69: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 70: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 71: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 72: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 73: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 74: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 75: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 76: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 77: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 78: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 79: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 80: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
Table 81: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
